MiR-125b promotes cell proliferation by directly targeting Lin28 in glioblastoma stem cells with low expression levels of miR-125b

NeuroReport

Volumn 25, Issue 5, 2014, Pages 289-296

  Wan, Yi ^a   Sun, Guan ^b   Wang, Zhimin ^a   Guo, Jun ^b   Shi, Lei ^c  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b NANTONG UNIVERSITY   (China)

^c KUNSHAN FIRST PEOPLE S HOSPITAL AFFILIATED TO JIANGSU UNIVERSITY   (China)

Author keywords

Basolateral amygdala; Conditioned place preference; Context; Heroin; Reinstatement; Renewal

Indexed keywords

CAENORHABDITIS ELEGANS PROTEIN; LIN28 PROTEIN; MICRORNA 125B; REGULATOR PROTEIN; UNCLASSIFIED DRUG; CD133 ANTIGEN; GLYCOPROTEIN; LEUKOCYTE ANTIGEN; LIN-28 PROTEIN, HUMAN; MICRORNA; MIRN125 MICRORNA, HUMAN; PEPTIDE; RNA BINDING PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL CYCLE ARREST; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL DEDIFFERENTIATION; CELL GROWTH; CELL PROLIFERATION; CONTROLLED STUDY; EMBRYONIC STEM CELL; GENE OVEREXPRESSION; GENETIC TRANSFECTION; GLIOBLASTOMA; HUMAN; HUMAN CELL; IN VITRO STUDY; MOLECULAR INTERACTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; STEM CELL; TARGET CELL; TUMOR GROWTH; ASTROCYTE; BRAIN; CANCER STEM CELL; CELL CULTURE; CELL CYCLE CHECKPOINT; DISEASE COURSE; G1 PHASE CELL CYCLE CHECKPOINT; GENE SILENCING; GENETICS; METABOLISM; NUCLEOTIDE SEQUENCE; PATHOPHYSIOLOGY; PHYSIOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANTIGENS, CD; ASTROCYTES; BASE SEQUENCE; BRAIN; CELL CYCLE CHECKPOINTS; CELL PROLIFERATION; CELLS, CULTURED; DISEASE PROGRESSION; G0 PHASE; G1 PHASE CELL CYCLE CHECKPOINTS; GENE KNOCKDOWN TECHNIQUES; GLIOBLASTOMA; GLYCOPROTEINS; HUMANS; MICRORNAS; NEOPLASTIC STEM CELLS; PEPTIDES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA-BINDING PROTEINS;

EID: 84896390714     PISSN: 09594965     EISSN: 1473558X     Source Type: Journal    
DOI: 10.1097/WNR.0000000000000085     Document Type: Article

References (20)

1. Stupp R, Tonn JC, Brada M, Pentheroudakis G. High-grade malignant glioma: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol 2010; 21:v190-v193.
2. Li Z,Wang H, Eyler CE, Hjelmeland AB, Rich JN. Turning cancer stem cells inside out: an exploration of glioma stem cell signaling pathways. J Biol Chem 2009; 284:16705-16709.
3. Zhang D, Jing Z, Qiu B, Wu A, Wang Y. Temozolomide decreases invasion of glioma stem cells by down-regulating TGF-b2. Oncol Rep 2011; 26: 901-908.
4. Hatfield SD, Shcherbata HR, Fischer KA, Nakahara K, Carthew RW, Ruohola-Baker H. Stem cell division is regulated by the microRNA pathway. Nature 2005; 435:974-978.
5. Shi L, Wan Y, Sun G, Gu X, Qian C, Yan W, et al. Functional differences of miR-125b on the invasion of primary glioblastoma CD133-negative cells and CD133-positive cells. Neuromolecular Med 2012; 14:303-316.
6. Shi L, Zhang J, Pan T, Zhou J, Gong W, Liu N, et al. MiR-125b is critical for the suppression of human U251 glioma stem cell proliferation. Brain Res 2010; 1312:120-126.
7. Moss EG, Lee RC, Ambros V. The cold shock domain protein LIN-28 controls developmental timing in C. elegans and is regulated by the lin-4 RNA. Cell 1997; 88:637-646.
8. Darling JL. The in vitro biology of human brain tumors. In: Thomas DGT, editor. Neuro-oncology: primary malignant brain tumors. Baltimore, MD: Johns Hopkins University Press; 1990. pp. 1-25.
9. Chen C, Ridzon DA, Broomer AJ, Zhou Z, Lee DH, Nguyen JT, et al. Real-time quantification of microRNAs by stem-loop RT-PCR. Nucleic Acids Res 2005; 33:e179.
10. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2 (-Delta Delta C(T)) Method. Methods 2001; 25:402-408.
11. Chang SF, Chang TK, Peng HH, Yeh YT, Lee DY, Yeh CR, et al. BMP-4 induction of arrest and differentiation of osteoblast-like cells via p21CIP1 and p27KIP1 regulation. Mol Endocrinol 2009; 23:1827-1838.
12. Yu J, Vodyanik MA, Smuga-Otto K, Antosiewicz-Bourget J, Frane JL, Tian S, et al. Induced pluripotent stem cell lines derived from human somatic cells. Science 2007; 318:1917-1920.
13. Lim LP, Lau NC, Garrett-Engele P, Grimson A, Schelter JM, Castle J, et al. Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs. Nature 2005; 433:769-773.
14. Zhang S,Wan Y, Pan T, Gu X, Qian C, Sun G, et al. MicroRNA-21 inhibitor sensitizes human glioblastoma U251 stem cells to chemotherapeutic drug temozolomide. J Mol Neurosci 2012; 47:346-356.
15. Shi L, Zhang S, Feng K, Wu F, Wan Y, Wang Z, et al. MicroRNA-125b-2 confers human glioblastoma stem cells resistance to temozolomide through the mitochondrial pathway of apoptosis. Int J Oncol 2012; 40:119-129.
16. Viswanathan SR, Daley GQ. Lin28: a microRNA regulator with a macro role. Cell 2010; 140:445-449.
17. Copley MR, Babovic S, Benz C, Knapp DJ, Beer PA, Kent DG, et al. The Lin28b-let-7-Hmga2 axis determines the higher self-renewal potential of fetal haematopoietic stem cells. Nat Cell Biol 2013; 15:916-925.
18. Mao X, Raabe EH, Maciaczyk J, Kahlert U, Nikkhah G, Eberhart CG. LIN28 is expressed in glioblastomas and promotes KRAS-mediated transformation of human neural stem cells. Cancer Res 2011; 71:3454.
19. Chaudhuria AA, Soa AY, Mehtaa A, Minisandrama A, Sinhaa N, Jonssonb VD, et al. Oncomir miR-125b regulates hematopoiesis by targeting the gene Lin28A. PNAS 2012; 109:4233-4238.
20. Wang J, Cao N, Yuan M, Cui H, Tang Y, Qin L, et al. MicroRNA-125b/Lin28 pathway contributes to the mesendodermal fate decision of embryonic stem cells. Stem Cells Dev 2012; 21:1524-1537.